^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    PD-1 knockout engineered T cells

    i
    Other names: PD-1 knockout engineered T cells, PD-1 Knockout T Cells
    Associations

    News

    Trials
    Company:
    Chengdu MedGenCell
    Drug class:
    PD1 inhibitor
    Related drugs:
    Associations

    News

    Trials
    over3years
    PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer (clinicaltrials.gov)
    P1, N=12, Completed, Sichuan University | Active, not recruiting --> Completed
    Clinical • Trial completion • PD(L)-1 Biomarker • IO biomarker
    |
    EGFR (Epidermal growth factor receptor) • ALK (Anaplastic lymphoma kinase) • PD-1 (Programmed cell death 1) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL10 (Interleukin 10)
    |
    ALK positive
    |
    PD-1 knockout engineered T cells